| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Pitolisant hydrochloride |
| Brand | Wakix® |
| Indication | For the treatment of narcolepsy with or without cataplexy and should be initiated by a physician experienced in the treatment of sleep disorders. |
| Assessment Process | |
| Rapid review commissioned | 12/06/2017 |
| Rapid review completed | 15/06/2017 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |